SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Precision BioSciences reports PBGENE-HBV data at AASLD meeting

The company said pgRNA was undetectable in 100% of evaluable patients at the expected go-forward.

DTIL

Related stories